ClinicalTrials HQ

JAK Inhibitor Dose TAPering Strategy Study

JAK Inhibitor Dose TAPering Strategy Study

Recruiting · NCT06687551 · Registry updated 2026-08-07
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
JAK Inhibitor Dose TAPering Strategy StudySkin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritisRecruitingPhase 42026-08-07NCT06687551

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
University Hospital, Toulouse216

24 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CHRU de NANCYNancyFrance15
CHU d'AmiensAmiensFrance13
CHU de Clermont-FerrandClermont-FerrandFrance35
CHU de RouenRouenFrance37
CHU de ToursToursFrance16
CHU Dupuytren 2LimogesFrance1
CHU Le MansLe MansFrance4
GH Paris Saint-JosephParisFrance2
Groupe hospitalier Pitié-SalpêtrièreParisFrance4
Hopital CochinParisFrance9
Hopital LariboisièreParisFrance1
Hopital Maison BlancheReimsFrance1
Hopital NordSaint-EtienneFrance1
Hopital Saint AntoineParisFrance8
Hôpital BicêtreParisFrance3
Hôpital HautepierreStrasbourgFrance4
Hôpital LAPEYRONIEMontpellierFrance2
Hôpital Pasteur 2NiceFrance1
Hôpital PellegrinBordeauxFrance6
Hôpital Saint PhilibertLilleFrance1
Hôpital Sainte MargueriteMarseilleFrance1
La Cavale BlancheBrestFrance1
Nouvel Hôpital Orléans La SourceOrléansFrance1
UH ToulouseToulouseFrance1